The Entourage Effect has been named as a finalist in the Australian Financial Review’s Most Innovative Company awards 2025.
The wholesaler was among those shortlisted in the healthcare category for its development of Care Effect, a tech platform built by the team behind Canview.
Care Effect offers an integrated system connecting patients, prescribers, pharmacies and suppliers.
The Entourage Effect chief technology officer, Adam Gilmore, said: “Innovation in healthcare is about more than technology — it’s about creating systems that give people better access, clarity, and confidence in their treatment journey.
“With Care Effect, our goal has always been to set a new standard for how patients, practitioners, and pharmacies work together. Being recognised by the AFR as one of the most innovative companies in healthcare affirms that vision, and inspires us to keep pushing boundaries to deliver real impact where it matters most — in people’s lives.”
The awards dinner takes place at the Four Seasons Hotel in Sydney on October 28.
Bioxyne
Bioxyne has listed on the Frankfurt Stock Exchange (FSE) with the company saying it will provide greater access to European Investors.
Chief executive Sam Watson said the move aligns with its increased focus on Europe, with Germany a “pivotal” market.
“Approximately 95% of the German market is focused on dried flower which aligns with our core strength in processing and packaging GMP-certified cannabis flower,” he said. “The dual listing [on the ASX and FSE] and European engagement program will provide increased opportunities to communicate with investors and stakeholders.”
The company has appointed Dr Reiter IR as its European investor relations specialist, with a particular focus on broadening Bioxyne’s investor base in Austria and Switzerland, in addition to Germany.
Nimbin information night
Long-time cannabis advocates Dr Andrew Katelaris and Andrew Kavasilas will co-host a medical cannabis patient information symposium at Nimbin Town Hall this Saturday, held in memory of the late Dr Theresa Towpik.
The event, running from 11am to 4pm, aims to educate the public about the medical use of cannabis oils and extracts for patients who do not smoke or use cannabis recreationally.
“We aim to reach individuals who may have never used cannabis and are interested in its potential benefits without the effects of intoxication,” Kavasilas said.
“It’s important to recognise that these oils and extracts are quite different from traditional perceptions of medical cannabis.”
Kavasilas said the day would help people “gain awareness of the current scientific understanding of medical cannabis” and hear from researchers on the challenges of studying the plant and how it interacts differently with each patient.
For further information, call Andrew Kavasilas (0427 891 968) or Dr Andrew Katelaris (0467 365 964).